An ombudsman has been appointed to monitor patient care at The Villages Health, which is navigating its way through bankruptcy and a possible sale.

Humana Inc. (NYSE: HUM) touted “solid” second-quarter results and emphasized a multi-year transformation centered on scalable growth, cost reduction and ...

July 30, 2025Humana Inc. misses on earnings expectations. Reported EPS is $6.27 EPS, expectations were $6.32. Operator: Good ...

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised ...

Despite challenges in the home health sector, Humana remains confident in CenterWell’s ability to drive enterprise-wide ...

Humana’s results showed GAAP revenue growth and a non-GAAP earnings beat against analyst expectations. Revenue climbed by approximately 9.6% year over year to $32.4 billion (GAAP). However, adjusted ...

Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted ...

Humana's Q2 2025 earnings showcase raised EPS guidance, driven by CenterWell Pharmacy outperformance and MA membership gains.

Humana raised its annual profit forecast after beating quarterly estimates on Wednesday, as the U.S. health insurer succeeded ...

Humana beat Q2 EPS and revenue estimates and raised its 2025 outlook, driven by strong PDP growth and higher CenterWell patient volumes.

Humana Wednesday reported $545 million in second quarter profits as the health insurer’s medical cost trends fell in line ...

Humana (HUM) stock jumps as the company with its Q2 results lifts its 2025 outlook, citing strength in its Medicare Advantage ...